News | January 01, 2023
Briefs: Kilitch Drugs India, Family Care Hospitals and Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
The Institute will focus on increasing preparedness and laboratory capabilities for identification of novel and unknown zoonotic agents
These satellite institutes will further strengthen the research, international collaborations and facilitate affordable Ayush services for the larger community.
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
The company has reported total income of Rs. 1097.78 crores during the period ended June 30, 2022.
Patritumab deruxtecan is a specifically designed potential first-in-class HER3 directed antibody drug conjugate (ADC) discovered and being developed by Daiichi Sankyo.
Ministry of Ayush has fast tracked up-gradation and construction of various Ayush Infrastructure across the country
The award was presented to her during a virtual ceremony on the occasion of 8th International Day of Yoga on 21st June 2022.
Subscribe To Our Newsletter & Stay Updated
